Fundamental Data for DDSS

LABOPHARM(NSDQ:DDSS)

Labopharm Inc. is an international, specialty pharmaceutical company focused on the development of drugs incorporating Contramid, the Company''s proprietary advanced controlled-release technology. Labopharm''s lead product, a once-daily formulation of the analgesic tramadol, is marketed in Germany and has received regulatory approval in European countries. The Company''s pipeline includes a combination of proprietary and partnered programs with products both in clinical trials and in preclinical development.

# Employees: 0

Address: ,,,

Phone:

Fax:

Website:

Email:

Sector: Medical

Industry: MED-DRUGS

Executive Officers

No Information

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 2/25/2010

Mean EPS (Next Qtr): ($0.10)

Mean EPS (Year): ($0.42)

Mean Estimate(Long Term): ($0.01)

P/E Ratio(Based on EPS estimate): -0.010

Number of Estimates: 4

Shares Performance

Period	DDSS	Compare to S&P
YTD	-22.53 %	-35.88 %
4 Weeks	-9.62 %	-10.59 %
12 Weeks	-1.40 %	-7.04 %

Shares Information

Analyst Coverage: Y

Avg Volume: 345394

Shares Outstanding: 57M

Market Cap: $0.08B

52 Week High: $2.56

52 Week Low: $0.33

P/E Ratio: -0.010

PEG Ratio: -0.010

Split: On 1/1/1990 DDSS split by factor of 2.000

Earnings Performance

EPS Growth in Last Quarter: -37.50 %

EPS Growth in Last Year: -10.00 %

Sales Growth in Last Quarter: 6.47 %

Sales Growth in Last Quarter: -31.46 %

Financials

Qtr Book Value: ($0.01)

Cash Flow/Share: ($0.01)

Change in Payout Ratio: -0.010

Price/Sales: 4.080